First report on nasal myiasis in an alpaca "Vicugna pacos" - a case report.

BACKGROUND: An infestation of bot fly larvae causes myiasis which is known to cause respiratory symptoms in ruminants. There are reports of bot fly larvae in llamas, but to our knowledge there are no previous reports of nasal myiasis due to bot flies in alpacas ("Vicugna pacos"). CASE PRESENTATION: The following case report describes a neutered male alpaca showing sneezing and mild nasal discharge. Endoscopic examination of the upper respiratory tract revealed bot fly larvae in one nostril. After treatment with doramectin, there was no evidence of living bot fly larvae visible in the nostril. CONCLUSION: Bot fly larvae should be considered as a potential cause of respiratory symptoms in alpacas. In the present case, a treatment with doramectin was successful.

Membrane-acting biomimetic peptoids against visceral leishmaniasis.

Visceral leishmaniasis (VL) is among the most neglected tropical diseases in the world. Drug cell permeability is essential for killing the intracellular residing parasites responsible for VL, making cell-permeating peptides a logical choice to address VL. Unfortunately, the limited biological stability of peptides restricts their usage. Sequence-specific oligo-N-substituted glycines ('peptoids') are a class of peptide mimics that offers an excellent alternative to peptides in terms of ease of synthesis and good biostability. We tested peptoids against the parasite Leishmania donovani in both forms, that is, intracellular amastigotes and promastigotes. N-alkyl hydrophobic chain addition (lipidation) and bromination of oligopeptoids yielded compounds with good antileishmanial activity against both forms, showing the promise of these antiparasitic peptoids as potential drug candidates to treat VL.